Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Liabilities and Shareholders Equity (2016 - 2025)

GeoVax Labs (GOVX) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $6.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 39.42% to $6.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $31.1 million, a 11.57% increase, with the full-year FY2024 number at $8.2 million, down 12.14% from a year prior.
  • Liabilities and Shareholders Equity was $6.7 million for Q3 2025 at GeoVax Labs, up from $5.4 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $38.6 million in Q3 2022 to a low of $3.4 million in Q1 2024.
  • A 5-year average of $16.6 million and a median of $16.2 million in 2023 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: skyrocketed 2441.48% in 2021, then plummeted 87.75% in 2024.
  • GeoVax Labs' Liabilities and Shareholders Equity stood at $11.8 million in 2021, then surged by 165.73% to $31.3 million in 2022, then crashed by 70.39% to $9.3 million in 2023, then dropped by 12.14% to $8.2 million in 2024, then fell by 17.47% to $6.7 million in 2025.
  • Per Business Quant, the three most recent readings for GOVX's Liabilities and Shareholders Equity are $6.7 million (Q3 2025), $5.4 million (Q2 2025), and $10.8 million (Q1 2025).